New research indicates that patients who stop using popular slimming jabs like Wegovy and Mounjaro can put back on lost weight far faster than those who halt traditional lifestyle programs.
Published data in a leading health publication points out that while obese individuals frequently drop substantial amounts of their body weight while undergoing treatment, the mass returns at an average rate of nearly a kilo each month upon discontinuation.
"Individuals using such treatments must be informed of the risk of rapid rebound weight gain when the therapy concludes," stated researcher Dr. Susan Jebb.
This pace of recovery suggests a reversion to starting weight in about one and a half years.
Analyzing Therapies
The research, which reviewed 37 of trials involving thousands of participants, compared the effects of these new drugs with conventional dieting.
Scientists note that people who lose weight through lifestyle changes alone generally see a more gradual creep back—approximately 0.1 kg a month—once they finish.
The Reason for the Rapid Rebound
Nutrition scientists believe the mode of action of the injections is key to understanding the amplified weight return.
The injections copy a natural hormone called GLP-1, which controls feelings of fullness.
"Artificially providing the hormone concentrations far above than the body's typical production may cause the system to generate a reduced amount of its own natural GLP-1, and could lessen sensitivity to its actions," explained Dr. Adam Collins, a nutrition specialist.
"Discontinuation of this hormone supplement results in hunger is no longer kept in check, making binge eating much more probable."
An Ongoing Issue?
Health authorities advise the injections for people with weight-linked medical conditions, accompanied by recommended diet and exercise modifications.
Professionals say that, considering the likelihood of weight regain, the therapy should be considered life-long.
This view is reinforced by drug manufacturers, who say that the results "emphasize the persistent nature of obesity," comparing it to managing conditions like hypertension.
User Experiences
Users who have come off the jabs describe a sudden return of cravings.
"It felt as if something that goes on and I was suddenly starving," recalled an individual.
The struggle is exacerbated if users have not developed lasting lifestyle or habit changes during treatment.
Growing Interest
Survey data suggest that a significant number of people in the UK have tried these injections in the last 12 months, with interest remaining high.
- Adoption is higher among females than men.
- The 40s and 50s demographic shows the highest level of interest.
- A large proportion access the drugs through private healthcare rather than the NHS.
In conclusion, experts stress that while these medications are effective agents for shedding pounds, they are not a permanent fix and lasting health benefits relies on integrated lifestyle support.
